In patients with early-stage ovarian cancer, a high prognostic nutritional index improved survival, while a high systemic immune-inflammation index worsened it. In advanced stages, both affected ...

This review aims to provide an overview of VMP1’s multifaceted roles and its implications in disease pathology. VMP1’s functions extend beyond autophagy, with emerging evidence highlighting its ...

Nearly half of advanced ovarian cancer patients relapsed after first-line PARP inhibitor maintenance, emphasizing the need for refined postrecurrence strategies. BRCA mutation carriers were more ...